Boehringer Ingelheim Peru
The Boehringer Ingelheim group, with over 100 years of presence worldwide, is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
The research and development have been the basis of success of Boehringer Ingelheim and the Innovation still remains in the new drug for treatment of diseases with unmet therapeutic needs.
This company produces medicines for human and animal healthcare. The area of human use drugs encompasses lines prescription medicines, consumer products, biopharmaceuticals products and operations (production of chemical substances and production pharma) .
In South America
Since September 1st 2005, Boehringer Ingelheim Perú is part of the South America Regional Operational Unit, formed by Argentina, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela.